Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

Clinical trial NCT00444925 · COMPLETED

Trial details

NCT number: NCT00444925
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overactive Bladder

Start date: 2007-04-01
Primary completion: 2008-07-01
Enrollment: 1712

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.